Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Yale School of Medicine

M. Minkin, E. Ratner

Referral to Eye Care Provider for Management of Ocular Toxicity Asso…

Debra Richardson

ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comparing…

Insights from 2023 ESGO Annual Meeting

A. Clamp

Updates in Ovarian Cancer: Risk Reduction Strategies and Mirvetuxima…

Nebraska Oncology Society

M. Clark

2023 ASCO® Direct Philadelphia: Phase 3 OVHIPEC-1 Trial Final Surviv…

Total Health

A. Smith

SGO 2023 Phase 3 UP-NEXT Trial: Upifitamab Rilsodotin, a NaPi2b-Dire…

SGO 2023 Conference Coverage on VuMedi

D. Richardson

The Role of Surgery in Stage IV Ovarian Cancer

Insights from 2024 ESMO Gynaecological Cancers Congress

C. Fotopoulou

Expert Panel Case Discussion: Stage 4A High-Grade Serous Epithelial …

Integrity CE

M. Murphy, E. Teplinsky, M. Finkel

Updates in Gynecologic Cancers: Ovarian Cancer

Yale Cancer Center

M. Clark

Role of Zinc Finger Protein 217 (ZNF217) in Ovarian Cancer Metastasis

Ovarian Cancer Midwest Focus, University of Minnesota

A. Padmanabhan

Detection of Residual Peritoneal Metastases Following Cytoreductive …

Penn Medicine Abramson Cancer Center

P. Wagner

2020 ASCO Update on PARPi in Ovarian Cancer: Is BRCA Related to Ther…

2020 ASCO Virtual Direct™ Highlights

S. Temkin